These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 31632198)

  • 1. Overexpression of CENPF correlates with poor prognosis and tumor bone metastasis in breast cancer.
    Sun J; Huang J; Lan J; Zhou K; Gao Y; Song Z; Deng Y; Liu L; Dong Y; Liu X
    Cancer Cell Int; 2019; 19():264. PubMed ID: 31632198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced expression of centromere protein F predicts clinical progression and prognosis in patients with prostate cancer.
    Zhuo YJ; Xi M; Wan YP; Hua W; Liu YL; Wan S; Zhou YL; Luo HW; Wu SL; Zhong WD; Wu CL
    Int J Mol Med; 2015 Apr; 35(4):966-72. PubMed ID: 25647485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive Analysis of the Expression and Prognostic Significance of the CENP Family in Breast Cancer.
    Liu X; Liu Y
    Int J Gen Med; 2022; 15():3471-3482. PubMed ID: 35378917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Centromere Protein F (
    Huang Y; Chen X; Wang L; Wang T; Tang X; Su X
    J Cancer; 2021; 12(10):2933-2951. PubMed ID: 33854594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of CENPF is associated with progression and poor prognosis of lung adenocarcinoma.
    Li MX; Zhang MY; Dong HH; Li AJ; Teng HF; Liu AL; Xu N; Qu YQ
    Int J Med Sci; 2021; 18(2):494-504. PubMed ID: 33390818
    [No Abstract]   [Full Text] [Related]  

  • 6. Centromere protein F and Forkhead box M1 correlation with prognosis of non-small cell lung cancer.
    Li R; Wang X; Zhao X; Zhang X; Chen H; Ma Y; Liu Y
    Oncol Lett; 2020 Feb; 19(2):1368-1374. PubMed ID: 31966068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CENPF promotes the proliferation of renal cell carcinoma
    Zhang J; Wang Z; Liu Z; Chen Z; Jiang J; Ji Y; Zhang Y; Zhu H; Zheng B
    Transl Androl Urol; 2023 Feb; 12(2):320-329. PubMed ID: 36915885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CENPF promotes papillary thyroid cancer progression by mediating cell proliferation and apoptosis.
    Han Y; Xu S; Cheng K; Diao C; Liu S; Zou W; Bi Y
    Exp Ther Med; 2021 Apr; 21(4):401. PubMed ID: 33680123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell Cycle-Related Centromere Protein F Deficiency Suppresses Ovarian Cancer Cell Growth by Inducing Ferroptosis.
    Liu X; Guo L; Suo Y; Tang X; Zhu T; Zhao T; Zhang W; Zhang P
    Gynecol Obstet Invest; 2024 May; ():1-13. PubMed ID: 38723616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CENPF as an independent prognostic and metastasis biomarker corresponding to CD4+ memory T cells in cutaneous melanoma.
    Li M; Zhao J; Yang R; Cai R; Liu X; Xie J; Shu B; Qi S
    Cancer Sci; 2022 Apr; 113(4):1220-1234. PubMed ID: 35189004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of centromere protein F is linked to aggressive prostate cancers.
    Göbel C; Özden C; Schroeder C; Hube-Magg C; Kluth M; Möller-Koop C; Neubauer E; Hinsch A; Jacobsen F; Simon R; Sauter G; Michl U; Pehrke D; Huland H; Graefen M; Schlomm T; Luebke AM
    Cancer Manag Res; 2018; 10():5491-5504. PubMed ID: 30519097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrative analysis of prognostic value and immune infiltration of spindle and kinetochore-associated family members in breast cancer.
    Ding J; He X; Wang J; Cao G; Chen S; Yuan L; Chen B; Xiong M
    Bioengineered; 2021 Dec; 12(2):10905-10923. PubMed ID: 34845974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FAM49B promotes breast cancer proliferation, metastasis, and chemoresistance by stabilizing ELAVL1 protein and regulating downstream Rab10/TLR4 pathway.
    Li Y; Xiong Y; Wang Z; Han J; Shi S; He J; Shen N; Wu W; Wang R; Lv W; Deng Y; Liu W
    Cancer Cell Int; 2021 Oct; 21(1):534. PubMed ID: 34645466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of potential key genes and functional role of CENPF in osteosarcoma using bioinformatics and experimental analysis.
    Ma Y; Guo J; Li D; Cai X
    Exp Ther Med; 2022 Jan; 23(1):80. PubMed ID: 34934449
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Li Y; Wang W; Wu X; Ling S; Ma Y; Huang P
    Ann Transl Med; 2021 May; 9(10):892. PubMed ID: 34164526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rac3 Expression and its Clinicopathological Significance in Patients With Bladder Cancer.
    Chen M; Nie Z; Cao H; Gao Y; Wen X; Zhang C; Zhang S
    Pathol Oncol Res; 2021; 27():598460. PubMed ID: 34257551
    [No Abstract]   [Full Text] [Related]  

  • 17. Characterization of the oncogenic function of centromere protein F in hepatocellular carcinoma.
    Dai Y; Liu L; Zeng T; Zhu YH; Li J; Chen L; Li Y; Yuan YF; Ma S; Guan XY
    Biochem Biophys Res Commun; 2013 Jul; 436(4):711-8. PubMed ID: 23791740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ClpP regulates breast cancer cell proliferation, invasion and apoptosis by modulating the Src/PI3K/Akt signaling pathway.
    Luo J; Zeng B; Tao C; Lu M; Ren G
    PeerJ; 2020; 8():e8754. PubMed ID: 32195060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of CLEC3A promotes tumor progression and poor prognosis in breast invasive ductal cancer.
    Ni J; Peng Y; Yang FL; Xi X; Huang XW; He C
    Onco Targets Ther; 2018; 11():3303-3312. PubMed ID: 29892197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hsa_circ_001569 is an unfavorable prognostic factor and promotes cell proliferation and metastasis by modulating PI3K-AKT pathway in breast cancer.
    Xu JH; Wang Y; Xu D
    Cancer Biomark; 2019; 25(2):193-201. PubMed ID: 31104012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.